Skip to content

Effects of aromatherapy with Rosa Damascena on anxiety of mothers with premature infants

Evaluation effects of aromatherapy with Rosa Damascena on anxiety of mothers with premature infants admitted to the neonatal intensive care unit (NICU)

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20201012049007N1
Enrollment
80
Registered
2021-07-11
Start date
2021-07-23
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety. Generalized anxiety disorder

Interventions

Intervention 1: Intervention group: For 10 nights, aromatherapy with 10% Damasak rose essence, 20 minutes before going to bed, 5 drops of it is poured on a piece of 2 * 2 pieces of cotton and inhale f

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Mothers aged 18-45 years Ability and willingness to participate in the study Satisfaction to participate in the study Has a premature baby admitted to the neonatal intensive care unit of Mahdieh Hospital in Tehran Having anxiety (with any score)

Exclusion criteria

Exclusion criteria: Whenever a mother gives up from participating in the study after entering the study Whenever a baby dies for any reason during the study Headache, infection and bleeding after the start of the study that requires medical intervention History of any allergies to Rosa Damascena History of any drug allergies (according to the mother statement) Have a history of allergies to herbal medicines (according to the mother statement) A mother takes medicine to relieve anxiety (according to the mother statement) A mother uses non-pharmacological methods such as meditation, yoga, acupuncture to relieve anxiety (according to the mother statement)

Design outcomes

Primary

MeasureTime frame
Anxiety score in Spielberger questionnaire. Timepoint: Before the intervention, after 10 days. Method of measurement: Spielberger Anxiety Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Hashemi

Shahid Beheshti University of Medical Sciences

fatemehashemi2075@yahoo.com+98 21 8865 5366

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026